Establishing (177)Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer

Clinical (177)Lu-PSMA-617 radioligand therapy (RLT) is applied in advanced-stage prostate cancer. However, to the best of our knowledge murine models to study the biologic effects of various activity levels have not been established. The aim of this study was to optimize specific and total activity...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Nucl Med
Главные авторы: Fendler, Wolfgang P., Stuparu, Andreea D., Evans-Axelsson, Susan, Lückerath, Katharina, Wei, Liu, Kim, Woosuk, Poddar, Soumya, Said, Jonathan, Radu, Caius G., Eiber, Matthias, Czernin, Johannes, Slavik, Roger, Herrmann, Ken
Формат: Artigo
Язык:Inglês
Опубликовано: Society of Nuclear Medicine 2017
Предметы:
Theranostics
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944167/
https://ncbi.nlm.nih.gov/pubmed/28546332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193359
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы